drug

Shigetec

Phase 2updated 3mo ago

by EveliQure Biotechnologies GmbH

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying Shigetec

phase1ShigETEC Vaccine Study in Bangladeshcompletedn=196
phase2Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Oldrecruitingn=72

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 2m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

Shigetec

Phase 2updated 3mo ago

by EveliQure Biotechnologies GmbH

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying Shigetec

phase1ShigETEC Vaccine Study in Bangladeshcompletedn=196
phase2Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Oldrecruitingn=72

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 2m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

Shigetec

all catalysts(0)

Trials studying Shigetec

News(0)

Report a data issue

comments(0)

Shigetec

all catalysts(0)

Trials studying Shigetec

News(0)

Report a data issue

comments(0)